name

Marion Bähler

Managing Associate
Firm Logo

Walder Wyss Ltd.

Zurich, Switzerland
    Local Time: Thursday 18:43

Practice Expertise

  • Corporate & Commercial
  • Healthcare & Life Sciences
  • Industry & Commerce
  • Private Equity & Venture Capital

Areas of Practice

  • Corporate & Commercial
  • Healthcare & Life Sciences
  • Industry & Commerce
  • Private Equity & Venture Capital
  • Mergers & Acquisitions
  • Private Equity & Venture Capital
  • View More

Profile

Marion Bähler is a managing associate in our Corporate/M&A-Team. Her preferred areas of practice include M&A, corporate, contract, stock exchange and capital market law. One focus of her work is on private equity and venture capital transactions. She regularly advises start-ups and investors on the entire range of venture capital aspects, including financing rounds, acquisitions, participation plans (ESOPs) and exits. She further advises companies on general corporate law matters, corporate governance and other legal issues surrounding their daily business.

Born in 1987, Marion Bähler studied at the University of Berne and UC Berkeley, School of Law. Before joining Walder Wyss, Marion Bähler worked as an intern at the Administrative Court of the Canton of Bern and as a lawyer in a leading Swiss business law firm in Zurich. She is registered with the Zurich Bar Registry and admitted to practice in all of Switzerland.

Her professional languages are German and English. She also speaks French.

Areas of Practice

  • Corporate & Commercial
  • Healthcare & Life Sciences
  • Industry & Commerce
  • Private Equity & Venture Capital
  • Mergers & Acquisitions
  • Private Equity & Venture Capital

Professional Career

Significant Accomplishments

Terra Quantum AG raises a total of USD 75 million in series A financing round

Terra Quantum raises USD 60m Series A Financing

Imburse USD 12 Mio. Series A Finanzierungsrunde

Walder Wyss berät Planted Foods AG bei CHF 17 Mio. Serie A Finanzierungsrunde

Beförderungen bei Walder Wyss

Arkin Holdings beteiligt sich an der Fu Gen AG

Wise Road Capital übernimmt Huba Control von Siemens

Sunrise übernimmt den Web-TV-Pionier Wilmaa

DiNAQOR AG hat einen Kooperations- und Lizenzvertrag mit BioMarin Pharmaceutical Inc. abgeschlossen

SEED erwirbt Mehrheitsbeteiligung an der Sensimed AG

Schweizer FinTech Startup Tradeplus24 mit CHF 120 Mio. Serie A Finanzierungsrunde

CHF 15,5 Millionen Finanzierungsrunde des Schweizer Startups Oculis SA

Chinesischer Tech-Riese Baidu investiert in Schweizer Startup aiCTX

Schweizer Auris Medical Holding AG (Nasdaq) implementiert „Reverse Share Split“ mittels Konzernfusion

Metall Zug (SIX: METN) übernimmt Mehrheit an der Haag-Streit Holding AG

Credit Suisse neue Investorin und Partnerin bei Tradeplus24

Articles


IPO Readiness - Stolpersteine auf dem Weg zum Börsengang

Meet our Firms and Professionals

WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.